Found 5 matching trials
A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid Tumors
PHASE1The main purpose of this study is to evaluate the safety of the colony-stim...
Location
Sarah Cannon Research Institute at HealthOne
A Study of LY3022855 In Participants With Breast or Prostate Cancer
PHASE1The main purpose of this study is to learn more about how the investigation...
Location
Cedars Sinai Medical Center
Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas
EARLY_PHASE1The purpose of this study is to evaluate whether combining cyclophosphamide...
Location
Sidney Kimmel Comprehensive Cancer Center
A Study of IMC-CS4 in Subjects With Advanced Solid Tumors
PHASE1A dose escalation study to establish the safety profile and characterize th...
Location
The Angeles Clinic & Research Institute
LY3022855 With BRAF/MEK Inhibition in Patients With Melanoma
PHASE1This research study is studying a combination of targeted therapies as a po...
Location
Dana Farber Cancer Institute